In terms of market performance, Bone Biologics Corp had a somewhat inconsistent run in. The highest value for the stock in the past year was $10.56 on 12/28/23, while the lowest value was $0.80 on 09/13/24. 52-week price history of BBLG Stock A stock’s 52-week
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The index has shown a price loss of -67.26% this year. Over the last six months, there has been a stronger performance of -15.43%.
A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Bone Biologics Corp’s current trading price is -85.61% away from its 52-week high, while its distance from the 52-week low is 90.00%. The stock’s
Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Bone Biologics Corp’s current trading price is -79.64% away from its 52-week high, while its distance from the 52-week low is 168.75%.
The market performance of Bone Biologics Corp has been somewhat unstable. Over the past year, the company’s stock achieved a high of $10.56 on 12/28/23, with the lowest value for the same timeframe being $1.00, recorded on 09/13/24. 52-week price history of BBLG Stock A
Shares of Bone Biologics Corporation (Nasdaq: BBLG) were up 7.37% at $0.3758 at the time of our latest check in after-hours trading, which was followed by a CEO letter to the company’s stockholders. What did the CEO of BBLG disclose to the shareholders? The letter
All rights reserved © 2024, Powered By Smart TechOne
